Total submissions: 8
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| KCCC/NGS Laboratory, |
RCV005235381 | SCV005880744 | benign | Premature ovarian failure 15 | 2025-02-01 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004975635 | SCV005580784 | likely benign | Inborn genetic diseases | 2024-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001788277 | SCV004218758 | benign | not provided | 2022-04-29 | criteria provided, single submitter | clinical testing | |
| Ce |
RCV001788277 | SCV004134042 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | FANCM: BP4, BP7 |
| Sema4, |
RCV002255432 | SCV002527345 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-12 | criteria provided, single submitter | curation | |
| Gene |
RCV001788277 | SCV002030872 | uncertain significance | not provided | 2024-09-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this variant does not alter splicing |
| Labcorp Genetics |
RCV000545488 | SCV000626366 | benign | Fanconi anemia | 2024-12-26 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV004537900 | SCV004740837 | likely benign | FANCM-related disorder | 2019-05-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |